Info Sheet
End-of-Phase II meetings: Where pivotal development decisions are made
A well-prepared End-of-Phase II (EOP2) meeting helps Sponsors align with regulators on pivotal trial design, evidence expectations and next-step strategy; mitigating risk downstream and before major Phase III investment is committed.